< Back to scientific publications

Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 4.26

The grey zone between autoimmune encephalitis and autoimmune-associated epilepsy

Authors: Morano A, Cerulli Irelli E, Fanella M, Zuliani L, Giallonardo AT, Di Bonaventura C.

Date: 2021

Scope of interest: Epilepsy/autoimmune diseases of the CNS


Read details
Magazine

Outcomes of allogenicstemcelltransplantation for secondary therapy-related acute myeloidleukaemia

Authors:

Date: 2012

Scope of interest: Haematology


Read details
Report/Poster of Convention/Congress Act

Cognitive Stimulation with Motor Activity Programs in Moderate Alzheimer’s Disease

Authors: A.M. Abbatecola, M. Coppola, M. Ciccarelli, C. Dimeo, E. Bottoni, M. Russo, G. Curcio (Atina, Sora, Cassino, L’ Aquila)

Date: 2018

Scope of interest: Dementia


Read details